Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2022 | Oct. 28, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2022 | |
Document Transition Report | false | |
Entity File Number | 1-12981 | |
Entity Registrant Name | AMETEK, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | 1100 Cassatt Road | |
Entity Address, City or Town | Berwyn | |
Entity Address, State or Province | PA | |
Entity Tax Identification Number | 14-1682544 | |
Entity Address, Postal Zip Code | 19312-1177 | |
City Area Code | 610 | |
Local Phone Number | 647-2121 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Title of 12(b) Security | Common Stock | |
Trading Symbol | AME | |
Security Exchange Name | NYSE | |
Entity Common Stock, Shares Outstanding | 229,654,397 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Entity Central Index Key | 0001037868 | |
Current Fiscal Year End Date | --12-31 |
Consolidated Statement of Incom
Consolidated Statement of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Net sales | $ 1,551,786 | $ 1,440,681 | $ 4,524,863 | $ 4,042,769 |
Cost of sales | 1,004,596 | 949,402 | 2,941,604 | 2,651,506 |
Selling, general and administrative | 162,670 | 153,716 | 480,657 | 443,744 |
Total operating expenses | 1,167,266 | 1,103,118 | 3,422,261 | 3,095,250 |
Operating income | 384,520 | 337,563 | 1,102,602 | 947,519 |
Interest expense | (20,245) | (20,476) | (60,165) | (59,865) |
Other income (expense), net | 3,227 | 2,581 | 7,752 | (3,775) |
Income before income taxes | 367,502 | 319,668 | 1,050,189 | 883,879 |
Provision for income taxes | 69,861 | 62,208 | 197,728 | 175,507 |
Net income | $ 297,641 | $ 257,460 | $ 852,461 | $ 708,372 |
Basic earnings per share (in usd per share) | $ 1.30 | $ 1.11 | $ 3.70 | $ 3.07 |
Diluted earnings per share (in usd per share) | $ 1.29 | $ 1.10 | $ 3.68 | $ 3.04 |
Weighted average common shares outstanding: | ||||
Basic shares (in shares) | 229,500 | 231,171 | 230,360 | 230,811 |
Diluted shares (in shares) | 230,714 | 233,000 | 231,675 | 232,712 |
Dividends declared and paid per share (in usd per shares) | $ 0.22 | $ 0.20 | $ 0.66 | $ 0.60 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Total comprehensive income | $ 215,568 | $ 240,076 | $ 694,902 | $ 688,575 |
Consolidated Balance Sheet
Consolidated Balance Sheet - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 309,944 | $ 346,772 |
Receivables, net | 876,460 | 829,213 |
Inventories, net | 1,025,130 | 769,175 |
Other current assets | 221,034 | 183,605 |
Total current assets | 2,432,568 | 2,128,765 |
Property, plant and equipment, net | 594,926 | 617,138 |
Right of use assets, net | 161,217 | 169,924 |
Goodwill | 5,190,196 | 5,238,726 |
Other intangibles, net | 3,254,243 | 3,368,629 |
Investments and other assets | 405,782 | 375,005 |
Total assets | 12,038,932 | 11,898,187 |
Current liabilities: | ||
Short-term borrowings and current portion of long-term debt, net | 272,027 | 315,093 |
Accounts payable | 524,255 | 470,252 |
Customer advanced payments | 332,244 | 298,728 |
Income taxes payable | 49,056 | 35,904 |
Accrued liabilities and other | 413,801 | 443,337 |
Total current liabilities | 1,591,383 | 1,563,314 |
Long-term debt, net | 2,085,364 | 2,229,148 |
Deferred income taxes | 696,091 | 719,675 |
Other long-term liabilities | 533,422 | 514,166 |
Total liabilities | 4,906,260 | 5,026,303 |
Stockholders’ equity: | ||
Common stock | 2,695 | 2,689 |
Capital in excess of par value | 1,059,079 | 1,012,526 |
Retained earnings | 8,600,938 | 7,900,113 |
Accumulated other comprehensive loss | (628,003) | (470,444) |
Treasury stock | (1,902,037) | (1,573,000) |
Total stockholders’ equity | 7,132,672 | 6,871,884 |
Total liabilities and stockholders’ equity | $ 12,038,932 | $ 11,898,187 |
Consolidated Statement of Stock
Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands | Total | Capital stock | Capital in excess of par value | Retained earnings | Accumulated foreign currency adjustment attributable to parent | Accumulated defined benefit plans adjustment attributable to parent | Accumulated other comprehensive (loss) income | Treasury stock |
Balance at the beginning of the year at Dec. 31, 2020 | $ 2,676 | $ 921,752 | $ 7,094,656 | $ (250,748) | $ (253,720) | $ (1,565,270) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Shares issued | 10 | |||||||
Issuance of common stock under employee stock plans | 29,544 | 7,309 | ||||||
Share-based compensation expense | 35,021 | |||||||
Net income | $ 708,372 | 708,372 | ||||||
Cash dividends paid | (138,345) | |||||||
Other | (1) | |||||||
Translation adjustments | (45,160) | |||||||
Change in long-term intercompany notes | (11,041) | |||||||
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively | 31,514 | |||||||
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively | 4,890 | |||||||
Purchase of treasury stock | (13,063) | |||||||
Balance at the end of the year at Sep. 30, 2021 | 6,558,396 | 2,686 | 986,317 | 7,664,682 | (275,435) | (248,830) | $ (524,265) | (1,571,024) |
Balance at the beginning of the year at Jun. 30, 2021 | 2,684 | 964,791 | 7,453,401 | (256,421) | (250,460) | (1,570,696) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Shares issued | 2 | |||||||
Issuance of common stock under employee stock plans | 10,098 | (143) | ||||||
Share-based compensation expense | 11,428 | |||||||
Net income | 257,460 | 257,460 | ||||||
Cash dividends paid | (46,178) | |||||||
Other | (1) | |||||||
Translation adjustments | (31,207) | |||||||
Change in long-term intercompany notes | (5,475) | |||||||
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively | 17,668 | |||||||
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively | 1,630 | |||||||
Purchase of treasury stock | (185) | |||||||
Balance at the end of the year at Sep. 30, 2021 | 6,558,396 | 2,686 | 986,317 | 7,664,682 | (275,435) | (248,830) | (524,265) | (1,571,024) |
Balance at the beginning of the year at Dec. 31, 2021 | 6,871,884 | 2,689 | 1,012,526 | 7,900,113 | (275,365) | (195,079) | (1,573,000) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Shares issued | 6 | |||||||
Issuance of common stock under employee stock plans | 11,966 | 2,387 | ||||||
Share-based compensation expense | 34,587 | |||||||
Net income | 852,461 | 852,461 | ||||||
Cash dividends paid | (151,635) | |||||||
Other | (1) | |||||||
Translation adjustments | (225,100) | |||||||
Change in long-term intercompany notes | (40,512) | |||||||
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively | 105,053 | |||||||
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively | 3,000 | |||||||
Purchase of treasury stock | (331,424) | |||||||
Balance at the end of the year at Sep. 30, 2022 | 7,132,672 | 2,695 | 1,059,079 | 8,600,938 | (435,924) | (192,079) | (628,003) | (1,902,037) |
Balance at the beginning of the year at Jun. 30, 2022 | 2,695 | 1,040,951 | 8,353,735 | (352,851) | (193,079) | (1,901,360) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Shares issued | 0 | |||||||
Issuance of common stock under employee stock plans | 6,068 | (632) | ||||||
Share-based compensation expense | 12,060 | |||||||
Net income | 297,641 | 297,641 | ||||||
Cash dividends paid | (50,438) | |||||||
Other | 0 | |||||||
Translation adjustments | (110,524) | |||||||
Change in long-term intercompany notes | (17,393) | |||||||
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively | 44,844 | |||||||
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively | 1,000 | |||||||
Purchase of treasury stock | (45) | |||||||
Balance at the end of the year at Sep. 30, 2022 | $ 7,132,672 | $ 2,695 | $ 1,059,079 | $ 8,600,938 | $ (435,924) | $ (192,079) | $ (628,003) | $ (1,902,037) |
Consolidated Statement of Sto_2
Consolidated Statement of Stockholders' Equity (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Statement of Stockholders' Equity [Abstract] | ||||
Common stock, par value (in usd per share) | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 |
Tax related to investment hedge instruments gain (loss) | $ (14,604) | $ (5,715) | $ (34,212) | $ (10,194) |
Tax related to amortization of net actuarial loss (gain) | $ (326) | $ (527) | $ (977) | $ (1,581) |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Operating activities: | ||
Net income | $ 852,461 | $ 708,372 |
Adjustments to reconcile net income to total operating activities: | ||
Depreciation and amortization | 230,968 | 214,494 |
Deferred income taxes | (32,889) | (7,209) |
Share-based compensation expense | 34,587 | 35,021 |
Gain on sale of business/investment | (3,584) | (6,349) |
Gain on sale of facilities | (7,054) | 0 |
Net change in assets and liabilities, net of acquisitions | (299,311) | (60,947) |
Pension contributions | (5,244) | (6,414) |
Other, net | (5,576) | 1,592 |
Total operating activities | 764,358 | 878,560 |
Investing activities: | ||
Additions to property, plant and equipment | (80,829) | (67,229) |
Purchases of businesses, net of cash acquired | (190,321) | (1,839,664) |
Proceeds from sale of business/investment | 3,734 | 12,000 |
Proceeds from sale of facilities | 11,754 | 0 |
Other, net | 124 | (291) |
Total investing activities | (255,538) | (1,895,184) |
Financing activities: | ||
Net change in short-term borrowings | (26,315) | 286,126 |
Repurchases of common stock | (331,424) | (13,063) |
Cash dividends paid | (151,635) | (138,345) |
Proceeds from stock option exercises | 23,241 | 42,301 |
Other, net | (15,056) | (5,818) |
Total financing activities | (501,189) | 171,201 |
Effect of exchange rate changes on cash and cash equivalents | (44,459) | (8,723) |
Decrease in cash and cash equivalents | (36,828) | (854,146) |
Cash and cash equivalents: | ||
Beginning of period | 346,772 | 1,212,822 |
End of period | $ 309,944 | $ 358,676 |
Basis of Presentation
Basis of Presentation | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of PresentationThe accompanying consolidated financial statements are unaudited. AMETEK, Inc. (the “Company”) believes that all adjustments (which primarily consist of normal recurring accruals) necessary for a fair presentation of the consolidated financial position of the Company at September 30, 2022, the consolidated results of its operations for the three and nine months ended September 30, 2022 and 2021 and its cash flows for the nine months ended September 30, 2022 and 2021 have been included. Quarterly results of operations are not necessarily indicative of results for the full year. The accompanying consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the U.S. Securities and Exchange Commission. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Recently Adopted Accounting Pronouncement In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ("ASU 2021-08"), which provides a single comprehensive accounting model for the acquisition of contract balances under ASC 805. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company early adopted the ASU on January 1, 2022, and the amendments in this ASU were applied on a prospective basis to all periods presented. The adoption of ASU 2021-08 did not impact the Company's consolidated results of operations, financial position, cash flows, or financial statement disclosures. |
Revenues
Revenues | 9 Months Ended |
Sep. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Revenues The outstanding contract asset and liability accounts were as follows: 2022 2021 (In thousands) Contract assets—January 1 $ 95,274 $ 68,971 Contract assets – September 30 111,687 82,986 Change in contract assets – increase (decrease) 16,413 14,015 Contract liabilities – January 1 328,816 215,093 Contract liabilities – September 30 371,411 311,674 Change in contract liabilities – (increase) decrease (42,595) (96,581) Net change $ (26,182) $ (82,566) The net change for the nine months ended September 30, 2022 was primarily driven by contract liabilities, specifically growth in advance payments from customers. For the nine months ended September 30, 2022 and 2021, the Company recognized revenue of $252.4 million and $179.1 million, respectively, that was previously included in the beginning balance of contract liabilities. Contract assets are reported as a component of Other current assets in the consolidated balance sheet. At September 30, 2022 and December 31, 2021, $39.2 million and $30.1 million of Customer advanced payments (contract liabilities), respectively, were recorded in Other long-term liabilities in the consolidated balance sheets. The remaining performance obligations not expected to be completed within one year as of September 30, 2022 and December 31, 2021 were $520.6 million and $342.5 million, respectively. Remaining performance obligations represent the transaction price of firm, non-cancelable orders, with expected delivery dates to customers greater than one year from the balance sheet date, for which the performance obligation is unsatisfied or partially unsatisfied. These performance obligations will be substantially satisfied within two Geographic Areas Net sales were attributed to geographic areas based on the location of the customer. Information about the Company’s operations in different geographic areas was as follows for the three and nine months ended September 30: Three months ended September 30, 2022 Nine months ended September 30, 2022 EIG EMG Total EIG EMG Total (In thousands) United States $ 554,048 $ 265,549 $ 819,597 $ 1,589,641 $ 737,362 $ 2,327,003 International (1) : United Kingdom 18,409 28,694 47,103 65,414 88,945 154,359 European Union countries 113,935 100,427 214,362 344,074 322,620 666,694 Asia 264,432 70,375 334,807 776,084 203,439 979,523 Other foreign countries 103,300 32,617 135,917 294,918 102,366 397,284 Total international 500,076 232,113 732,189 1,480,490 717,370 2,197,860 Consolidated net sales $ 1,054,124 $ 497,662 $ 1,551,786 $ 3,070,131 $ 1,454,732 $ 4,524,863 ________________ (1) Includes U.S. export sales of $415.4 million and $1,217.2 million for the three and nine months ended September 30, 2022. Three months ended September 30, 2021 Nine months ended September 30, 2021 EIG EMG Total EIG EMG Total (In thousands) United States $ 509,075 $ 230,524 $ 739,599 $ 1,393,015 $ 666,618 $ 2,059,633 International (1) : United Kingdom 25,358 32,846 58,204 67,954 91,465 159,419 European Union countries 117,035 102,069 219,104 338,556 300,970 639,526 Asia 242,063 65,624 307,687 657,478 192,267 849,745 Other foreign countries 88,284 27,803 116,087 249,670 84,776 334,446 Total international 472,740 228,342 701,082 1,313,658 669,478 1,983,136 Consolidated net sales $ 981,815 $ 458,866 $ 1,440,681 $ 2,706,673 $ 1,336,096 $ 4,042,769 ______________ (1) Includes U.S. export sales of $391.0 million and $1,087.3 million for the three and nine months ended September 30, 2021. Major Products and Services The Company’s major products and services in the reportable segments were as follows: Three months ended September 30, 2022 Nine months ended September 30, 2022 EIG EMG Total EIG EMG Total (In thousands) Process and analytical instrumentation $ 758,868 $ — $ 758,868 $ 2,219,821 $ — $ 2,219,821 Aerospace and power 295,256 143,689 438,945 850,310 407,771 1,258,081 Automation and engineered solutions — 353,973 353,973 — 1,046,961 1,046,961 Consolidated net sales $ 1,054,124 $ 497,662 $ 1,551,786 $ 3,070,131 $ 1,454,732 $ 4,524,863 Three months ended September 30, 2021 Nine months ended September 30, 2021 EIG EMG Total EIG EMG Total (In thousands) Process and analytical instrumentation $ 661,243 $ — $ 661,243 $ 1,881,923 $ — $ 1,881,923 Aerospace and power 320,572 130,671 451,243 824,750 379,310 1,204,060 Automation and engineered solutions — 328,195 328,195 — 956,786 956,786 Consolidated net sales $ 981,815 $ 458,866 $ 1,440,681 $ 2,706,673 $ 1,336,096 $ 4,042,769 Timing of Revenue Recognition Three months ended September 30, 2022 Nine months ended September 30, 2022 EIG EMG Total EIG EMG Total (In thousands) Products transferred at a point in time $ 869,455 $ 436,222 $ 1,305,677 $ 2,522,351 $ 1,272,382 $ 3,794,733 Products and services transferred over time 184,669 61,440 246,109 547,780 182,350 730,130 Consolidated net sales $ 1,054,124 $ 497,662 $ 1,551,786 $ 3,070,131 $ 1,454,732 $ 4,524,863 Three months ended September 30, 2021 Nine months ended September 30, 2021 EIG EMG Total EIG EMG Total (In thousands) Products transferred at a point in time $ 791,486 $ 413,062 $ 1,204,548 $ 2,206,252 $ 1,204,662 $ 3,410,914 Products and services transferred over time 190,329 45,804 236,133 500,421 131,434 631,855 Consolidated net sales $ 981,815 $ 458,866 $ 1,440,681 $ 2,706,673 $ 1,336,096 $ 4,042,769 Product Warranties The Company provides limited warranties in connection with the sale of its products. The warranty periods for products sold vary among the Company’s operations, but the majority do not exceed one year. The Company calculates its warranty expense provision based on its historical warranty experience and adjustments are made periodically to reflect actual warranty expenses. Product warranty obligations are reported as a component of Accrued liabilities and other in the consolidated balance sheet. Changes in the accrued product warranty obligation were as follows: Nine Months Ended September 30, 2022 2021 (In thousands) Balance at the beginning of the period $ 27,478 $ 27,839 Accruals for warranties issued during the period 8,530 8,379 Settlements made during the period (8,769) (9,112) Warranty accruals related to acquired businesses and other during the period (1,080) 2,227 Balance at the end of the period $ 26,159 $ 29,333 Accounts Receivable The Company maintains allowances for estimated losses resulting from the inability of customers to meet their financial obligations to the Company. The Company recognizes an allowance for credit losses, on all accounts receivable and contract assets, which considers risk of future credit losses based on factors such as historical experience, contract terms, as well as general and market business conditions, country, and political risk. Balances are written off when determined to be uncollectible. At September 30, 2022, the Company had $876.5 million of accounts receivable, net of allowances of $12.0 million. Changes in the allowance were not material for the three and nine months ended September 30, 2022. |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Sep. 30, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). Securities that are anti-dilutive have been excluded and are not significant. The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (In thousands) Weighted average shares: Basic shares 229,500 231,171 230,360 230,811 Equity-based compensation plans 1,214 1,829 1,315 1,901 Diluted shares 230,714 233,000 231,675 232,712 |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company utilizes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The following table provides the Company’s assets that are measured at fair value on a recurring basis, consistent with the fair value hierarchy, at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 Fair Value Fair Value (In thousands) Mutual fund investments $ 8,866 $ 10,703 The fair value of mutual fund investments, which are valued as level 1 investments, was based on quoted market prices. The mutual fund investments are shown as a component of investments and other assets on the consolidated balance sheet. For the nine months ended September 30, 2022 and 2021, gains and losses on the investments noted above were not significant. No transfers between level 1 and level 2 investments occurred during the nine months ended September 30, 2022 and 2021. Financial Instruments Cash, cash equivalents and mutual fund investments are recorded at fair value at September 30, 2022 and December 31, 2021 in the accompanying consolidated balance sheet. The following table provides the estimated fair values of the Company’s financial instrument liabilities, for which fair value is measured for disclosure purposes only, compared to the recorded amounts at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 Recorded Amount Fair Value Recorded Amount Fair Value (In thousands) Long-term debt (including current portion) $ (2,088,231) $ (1,910,792) $ (2,233,705) $ (2,378,930) The fair value of net short-term borrowings approximates the carrying value. Net short-term borrowings are valued as level 2 liabilities as they are corroborated by observable market data. The Company’s net long-term debt is all privately held with no public market for this debt, therefore, the fair value of net long-term debt was computed based on comparable current market data for similar debt instruments and is considered a level 3 liability. Foreign Currency |
Hedging Activities
Hedging Activities | 9 Months Ended |
Sep. 30, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Hedging Activities | Hedging ActivitiesThe Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations. As of September 30, 2022, these net investment hedges included British-pound-and Euro-denominated long-term debt. These borrowings were designed to create net investment hedges in certain designated foreign subsidiaries. The Company designated the British-pound- and Euro-denominated loans referred to above as hedging instruments to offset translation gains or losses on the net investment due to changes in the British pound and Euro exchange rates. These net investment hedges are evidenced by management’s contemporaneous documentation supporting the hedge designation. Any gain or loss on the hedging instruments (the debt) following hedge designation is reported in accumulated other comprehensive income in the same manner as the translation adjustment on the hedged investment based on changes in the spot rate, which is used to measure hedge effectiveness. At September 30, 2022, the Company had $250.4 million of British-pound-denominated loans, which were designated as a hedge against the net investment in British pound functional currency foreign subsidiaries. At September 30, 2022, the Company had $523.7 million in Euro-denominated loans, which were designated as a hedge against the net investment in Euro functional currency foreign subsidiaries. As a result of the British-pound- and Euro-denominated loans designated and 100% effective as net investment hedges, $139.3 million of pre-tax currency remeasurement gains have been included in the foreign currency translation component of other comprehensive income for the nine months ended September 30, 2022. |
Inventories, net
Inventories, net | 9 Months Ended |
Sep. 30, 2022 | |
Inventory Disclosure [Abstract] | |
Inventories, net | Inventories, net September 30, December 31, (In thousands) Finished goods and parts $ 128,409 $ 89,985 Work in process 151,456 122,356 Raw materials and purchased parts 745,265 556,834 Total inventories, net $ 1,025,130 $ 769,175 |
Leases
Leases | 9 Months Ended |
Sep. 30, 2022 | |
Leases [Abstract] | |
Leases | Leases The Company has commitments under operating leases for certain facilities, vehicles and equipment used in its operations. Cash used in operations for operating leases was not materially different from operating lease expense for the nine months ended September 30, 2022 and 2021. The Company's leases have a weighted average remaining lease term of approximately five years. Certain lease agreements contain provisions for future rent increases. The components of lease expense were as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) Operating lease cost $ 16,407 $ 13,560 $ 47,131 $ 37,083 Variable lease cost 2,479 1,737 7,131 4,609 Total lease cost $ 18,886 $ 15,297 $ 54,262 $ 41,692 Supplemental balance sheet information related to leases was as follows: September 30, December 31, (In thousands) Right of use assets, net $ 161,217 $ 169,924 Lease liabilities included in Accrued Liabilities and other 45,434 47,353 Lease liabilities included in Other long-term liabilities 121,382 129,101 Total lease liabilities $ 166,816 $ 176,454 Maturities of lease liabilities as of September 30, 2022 were as follows: Lease Liability Maturity Analysis Operating Leases (In thousands) Remaining 2022 $ 13,154 2023 46,850 2024 35,684 2025 26,797 2026 20,476 Thereafter 36,390 Total lease payments 179,351 Less: imputed interest 12,535 $ 166,816 The Company does not have any significant leases that have not yet commenced. |
Acquisitions
Acquisitions | 9 Months Ended |
Sep. 30, 2022 | |
Business Combinations [Abstract] | |
Acquisitions and Divestiture | Acquisitions Acquisitions The Company spent $190.3 million in cash, net of cash acquired, to acquire Navitar, Inc. in September 2022. Navitar is a market leader in the design, development and manufacturing of customized, fully integrated optical imaging systems, cameras, components and software. Navitar is part of EIG. The following table represents the allocation of the purchase price for the net assets of the Navitar acquisition based on the estimated fair values at acquisition (in millions): Property, plant and equipment $ 8.9 Goodwill 71.1 Other intangible assets 95.0 Net working capital and other (1) 15.3 Total cash paid $ 190.3 ________________ (1) Includes $5.5 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal. The amount allocated to goodwill is reflective of the benefits the Company expects to realize from the Navitar acquisition. Navitar's market leading optical components and solutions complement the Company's existing optics portfolio. The Company expects approximately $52 million of the goodwill relating to the Navitar acquisition will be tax deductible in future years. At September 30, 2022, the purchase price allocated to other intangible assets of $95.0 million consists of $15.2 million of indefinite-lived intangible trade names, which are not subject to amortization. The remaining $79.8 million of other intangible assets consists of $64.6 million of customer relationships, which are being amortized over a period of 17 years, and $15.2 million of purchased technology, which is being amortized over a period of 17 years. Amortization expense for each of the next five years for the 2022 acquisitions is expected to approximate $5 million per year. The Company finalized its measurements of certain tangible and intangible assets and liabilities for its November 2021 acquisition of Alphasense, which had no material impact to the consolidated statement of income and balance sheet. The Company is in the process of finalizing the measurement of the intangible assets and tangible assets and liabilities, as well as accounting for income taxes, for Navitar. The acquisition had an immaterial impact on reported net sales, net income, and diluted earnings per share for the three and nine months ended September 30, 2022. Had the acquisition been made at the beginning of 2022 or 2021, pro forma net sales, net income, and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021, would not have been materially different than the amounts reported. Acquisition subsequent to September 30, 2022 In October 2022, the Company acquired RTDS Technologies for 325.0 million Canadian dollars (approximately $240.0 million) in cash. RTDS is a leading provider of real-time power simulation systems used by utilities, and research and education institutions in the development and testing of the electric power grid and renewable energy applications. RTDS will join EIG. |
Goodwill
Goodwill | 9 Months Ended |
Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | Goodwill The changes in the carrying amounts of goodwill by segment were as follows: EIG EMG Total (In millions) Balance at December 31, 2021 $ 4,073.8 $ 1,164.9 $ 5,238.7 Goodwill acquired from 2022 acquisitions 71.1 — 71.1 Purchase price allocation adjustments and other 4.2 — 4.2 Foreign currency translation adjustments (70.1) (53.7) (123.8) Balance at September 30, 2022 $ 4,079.0 $ 1,111.2 $ 5,190.2 |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes At September 30, 2022, the Company had gross uncertain tax benefits of $170.0 million, of which $125.3 million, if recognized, would impact the effective tax rate. The following is a reconciliation of the liability for uncertain tax positions (in millions): Balance at December 31, 2021 $ 147.0 Additions for tax positions 23.5 Reductions for tax positions (0.5) Balance at September 30, 2022 $ 170.0 The additions above primarily reflect the tax positions for foreign tax planning initiatives. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. The amounts recognized in income tax expense for interest and penalties during the three and nine months ended September 30, 2022 and 2021 were not significant. |
Debt
Debt | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
Debt | DebtOn May 12, 2022, the Company along with certain of its foreign subsidiaries amended and restated its credit agreement dated as of September 22, 2011, as amended and restated as of March 10, 2016 and as further amended and restated as of October 30, 2018, with the lenders, JPMorgan Chase Bank, N.A., as Administrative Agent and Bank of America, N.A., PNC Bank, National Association, Trust Bank and Wells Fargo Bank, National Association, as Co-Syndication Agents. The credit agreement amends and restates the Company’s existing revolving credit facility to increase the size from $1.5 billion to $2.3 billion and terminates the $800 million term loan. The credit agreement places certain restrictions on allowable additional indebtedness. At September 30, 2022, the Company had $274.0 million outstanding on the revolver with a maturity date of May 2027. |
Share-Based Compensation
Share-Based Compensation | 9 Months Ended |
Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation | Share-Based Compensation The Company's share-based compensation plans are described in Note 11, Share-Based Compensation, to the consolidated financial statements in Part II, Item 8, filed on the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Share Based Compensation Expense Total share-based compensation expense was as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) Stock option expense $ 3,043 $ 2,768 $ 9,866 $ 10,017 Restricted stock expense 4,800 4,848 14,831 16,765 Performance restricted stock unit expense 4,217 3,812 9,890 8,239 Total pre-tax expense $ 12,060 $ 11,428 $ 34,587 $ 35,021 Pre-tax share-based compensation expense is included in the consolidated statement of income in either Cost of sales or Selling, general and administrative expenses, depending on where the recipient’s cash compensation is reported. Stock Options The fair value of each stock option grant is estimated on the grant date using a Black-Scholes-Merton option pricing model. The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated: Nine Months Ended Year Ended December 31, 2021 Expected volatility 24.5 % 24.2 % Expected term (years) 5.0 5.0 Risk-free interest rate 2.33 % 0.85 % Expected dividend yield 0.65 % 0.66 % Black-Scholes-Merton fair value per stock option granted $ 32.54 $ 25.63 The following is a summary of the Company’s stock option activity and related information: Shares Weighted Weighted Aggregate (In thousands) (Years) (In millions) Outstanding at December 31, 2021 3,352 $ 76.08 Granted 608 134.69 Exercised (357) 64.44 Forfeited (101) 107.73 Outstanding at September 30, 2022 3,502 $ 86.52 6.2 $ 110.4 Exercisable at September 30, 2022 2,374 $ 72.84 5.0 $ 97.8 The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2022 was $23.0 million. The total fair value of stock options vested during the nine months ended September 30, 2022 was $11.3 million. As of September 30, 2022, there was approximately $20.9 million of expected future pre-tax compensation expense related to the 1.1 million non-vested stock options outstanding, which is expected to be recognized over a weighted average period of approximately two years. Restricted Stock The following is a summary of the Company’s non-vested restricted stock activity and related information: Shares Weighted (In thousands) Non-vested restricted stock outstanding at December 31, 2021 413 $ 96.07 Granted 182 134.55 Vested (156) 86.31 Forfeited (42) 108.42 Non-vested restricted stock outstanding at September 30, 2022 397 $ 116.26 The total fair value of restricted stock vested during the nine months ended September 30, 2022 was $13.5 million. As of September 30, 2022, there was approximately $32.3 million of expected future pre-tax compensation expense related to the 0.4 million non-vested restricted shares outstanding, which is expected to be recognized over a weighted average period of approximately two years. Performance Restricted Stock Units In March 2022, the Company granted performance restricted stock units ("PRSU") to officers and certain key management-level employees. The PRSUs vest over a period up to three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which the Company achieves certain financial and market performance targets measured over the period from January 1 of the year of grant to December 31 of the third year. Half of the PRSUs were valued in a manner similar to restricted stock as the financial targets are based on the Company’s operating results, which represents a performance condition. The grant date fair value of these PRSUs are recognized as compensation expense over the vesting period based on the probable number of awards to vest at each reporting date. The other half of the PRSUs were valued using a Monte Carlo model as the performance target is related to the Company’s total shareholder return compared to a group of peer companies, which represents a market condition. The Company recognizes the grant date fair value of these awards as compensation expense ratably over the vesting period. The following is a summary of the Company’s non-vested performance restricted stock activity and related information: Shares Weighted (In thousands) Non-vested performance restricted stock outstanding at December 31, 2021 289 $ 85.29 Granted 87 134.69 Performance assumption change 1 66 81.76 Vested (161) 81.76 Forfeited (6) 98.07 Non-vested performance restricted stock outstanding at September 30, 2022 275 $ 101.98 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics. As of September 30, 2022, there was approximately $8.8 million of expected future pre-tax compensation expense related to the 0.3 million non-vested restricted shares outstanding, which is expected to be recognized over a weighted average period of less than one year. |
Retirement and Pension Plans
Retirement and Pension Plans | 9 Months Ended |
Sep. 30, 2022 | |
Retirement Benefits [Abstract] | |
Retirement and Pension Plans | Retirement and Pension Plans The components of net periodic pension benefit expense (income) were as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) Defined benefit plans: Service cost $ 1,290 $ 2,009 $ 3,995 $ 6,060 Interest cost 4,949 4,563 15,101 13,711 Expected return on plan assets (14,812) (14,172) (45,113) (42,567) Amortization of net actuarial loss and other 2,074 7,550 6,371 16,282 Pension income (6,499) (50) (19,646) (6,514) Other plans: Defined contribution plans 9,217 7,792 32,289 24,208 Foreign plans and other 2,027 2,074 6,422 6,431 Total other plans 11,244 9,866 38,711 30,639 Total net pension expense $ 4,745 $ 9,816 $ 19,065 $ 24,125 For defined benefit plans, the net periodic benefit income, other than the service cost component, is included in “Other (expense) income, net” in the consolidated statement of income. For the nine months ended September 30, 2022 and 2021, contributions to the Company’s defined benefit pension plans were $5.2 million and $6.4 million, respectively. The Company’s current estimate of 2022 contributions to its worldwide defined benefit pension plans is in line with the range disclosed in Note 12 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. |
Contingencies
Contingencies | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | Contingencies Asbestos Litigation The Company (including its subsidiaries) has been named as a defendant in a number of asbestos-related lawsuits. Certain of these lawsuits relate to a business which was acquired by the Company and do not involve products which were manufactured or sold by the Company. In connection with these lawsuits, the seller of such business has agreed to indemnify the Company against these claims (the “Indemnified Claims”). The Indemnified Claims have been tendered to, and are being defended by, such seller. The seller has met its obligations, in all respects, and the Company does not have any reason to believe such party would fail to fulfill its obligations in the future. To date, no judgments have been rendered against the Company as a result of any asbestos-related lawsuit. The Company believes that it has good and valid defenses to each of these claims and intends to defend them vigorously. Environmental Matters Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At September 30, 2022, the Company is named a Potentially Responsible Party (“PRP”) at 13 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned” sites). The Company is identified as a “de minimis” party in 12 of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. In eight of these sites, the Company has reached a tentative agreement on the cost of the de minimis settlement to satisfy its obligation and is awaiting executed agreements. The tentatively agreed-to settlement amounts are fully reserved. In the other four sites, the Company is continuing to investigate the accuracy of the alleged volume attributed to the Company as estimated by the parties primarily responsible for remedial activity at the sites to establish an appropriate settlement amount. At the remaining site where the Company is a non-de minimis PRP, the Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the best estimate. It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations. Total environmental reserves at September 30, 2022 and December 31, 2021 were $39.6 million and $37.2 million, respectively, for both non-owned and owned sites. For the nine months ended September 30, 2022, the Company recorded $8.8 million in reserves. Additionally, the Company spent $6.4 million on environmental matters for the nine months ended September 30, 2022. The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of these other parties also carry insurance coverage for some environmental matters. The Company believes it has established reserves for the environmental matters described above, which are sufficient to perform all known responsibilities under existing claims and consent orders. In the opinion of management, based on presently available information and the Company’s historical experience related to such matters, an adequate provision for probable costs has been made and the ultimate cost resulting from these actions is not expected to materially affect the consolidated results of operations, financial position or cash flows of the Company. |
Recent Accounting Pronounceme_2
Recent Accounting Pronouncements (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
Basis of Presentation | The accompanying consolidated financial statements are unaudited. AMETEK, Inc. (the “Company”) believes that all adjustments (which primarily consist of normal recurring accruals) necessary for a fair presentation of the consolidated financial position of the Company at September 30, 2022, the consolidated results of its operations for the three and nine months ended September 30, 2022 and 2021 and its cash flows for the nine months ended September 30, 2022 and 2021 have been included. Quarterly results of operations are not necessarily indicative of results for the full year. The accompanying consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the U.S. Securities and Exchange Commission. |
Recently Adopted Accounting Pronouncement | Recently Adopted Accounting Pronouncement In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ("ASU 2021-08"), which provides a single comprehensive accounting model for the acquisition of contract balances under ASC 805. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company early adopted the ASU on January 1, 2022, and the amendments in this ASU were applied on a prospective basis to all periods presented. The adoption of ASU 2021-08 did not impact the Company's consolidated results of operations, financial position, cash flows, or financial statement disclosures. |
Accounts Receivable | Accounts Receivable The Company maintains allowances for estimated losses resulting from the inability of customers to meet their financial obligations to the Company. The Company recognizes an allowance for credit losses, on all accounts receivable and contract assets, which considers risk of future credit losses based on factors such as historical experience, contract terms, as well as general and market business conditions, country, and political risk. Balances are written off when determined to be uncollectible. |
Revenues (Tables)
Revenues (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Outstanding Contract Asset and (Liability) Accounts | The outstanding contract asset and liability accounts were as follows: 2022 2021 (In thousands) Contract assets—January 1 $ 95,274 $ 68,971 Contract assets – September 30 111,687 82,986 Change in contract assets – increase (decrease) 16,413 14,015 Contract liabilities – January 1 328,816 215,093 Contract liabilities – September 30 371,411 311,674 Change in contract liabilities – (increase) decrease (42,595) (96,581) Net change $ (26,182) $ (82,566) |
Schedule of Revenue From External Customers by Geographic Areas | Information about the Company’s operations in different geographic areas was as follows for the three and nine months ended September 30: Three months ended September 30, 2022 Nine months ended September 30, 2022 EIG EMG Total EIG EMG Total (In thousands) United States $ 554,048 $ 265,549 $ 819,597 $ 1,589,641 $ 737,362 $ 2,327,003 International (1) : United Kingdom 18,409 28,694 47,103 65,414 88,945 154,359 European Union countries 113,935 100,427 214,362 344,074 322,620 666,694 Asia 264,432 70,375 334,807 776,084 203,439 979,523 Other foreign countries 103,300 32,617 135,917 294,918 102,366 397,284 Total international 500,076 232,113 732,189 1,480,490 717,370 2,197,860 Consolidated net sales $ 1,054,124 $ 497,662 $ 1,551,786 $ 3,070,131 $ 1,454,732 $ 4,524,863 ________________ (1) Includes U.S. export sales of $415.4 million and $1,217.2 million for the three and nine months ended September 30, 2022. Three months ended September 30, 2021 Nine months ended September 30, 2021 EIG EMG Total EIG EMG Total (In thousands) United States $ 509,075 $ 230,524 $ 739,599 $ 1,393,015 $ 666,618 $ 2,059,633 International (1) : United Kingdom 25,358 32,846 58,204 67,954 91,465 159,419 European Union countries 117,035 102,069 219,104 338,556 300,970 639,526 Asia 242,063 65,624 307,687 657,478 192,267 849,745 Other foreign countries 88,284 27,803 116,087 249,670 84,776 334,446 Total international 472,740 228,342 701,082 1,313,658 669,478 1,983,136 Consolidated net sales $ 981,815 $ 458,866 $ 1,440,681 $ 2,706,673 $ 1,336,096 $ 4,042,769 ______________ (1) Includes U.S. export sales of $391.0 million and $1,087.3 million for the three and nine months ended September 30, 2021. |
Schedule of Revenue From External Customers by Products and Services | The Company’s major products and services in the reportable segments were as follows: Three months ended September 30, 2022 Nine months ended September 30, 2022 EIG EMG Total EIG EMG Total (In thousands) Process and analytical instrumentation $ 758,868 $ — $ 758,868 $ 2,219,821 $ — $ 2,219,821 Aerospace and power 295,256 143,689 438,945 850,310 407,771 1,258,081 Automation and engineered solutions — 353,973 353,973 — 1,046,961 1,046,961 Consolidated net sales $ 1,054,124 $ 497,662 $ 1,551,786 $ 3,070,131 $ 1,454,732 $ 4,524,863 Three months ended September 30, 2021 Nine months ended September 30, 2021 EIG EMG Total EIG EMG Total (In thousands) Process and analytical instrumentation $ 661,243 $ — $ 661,243 $ 1,881,923 $ — $ 1,881,923 Aerospace and power 320,572 130,671 451,243 824,750 379,310 1,204,060 Automation and engineered solutions — 328,195 328,195 — 956,786 956,786 Consolidated net sales $ 981,815 $ 458,866 $ 1,440,681 $ 2,706,673 $ 1,336,096 $ 4,042,769 |
Schedule of Disaggregation of Revenue | Three months ended September 30, 2022 Nine months ended September 30, 2022 EIG EMG Total EIG EMG Total (In thousands) Products transferred at a point in time $ 869,455 $ 436,222 $ 1,305,677 $ 2,522,351 $ 1,272,382 $ 3,794,733 Products and services transferred over time 184,669 61,440 246,109 547,780 182,350 730,130 Consolidated net sales $ 1,054,124 $ 497,662 $ 1,551,786 $ 3,070,131 $ 1,454,732 $ 4,524,863 Three months ended September 30, 2021 Nine months ended September 30, 2021 EIG EMG Total EIG EMG Total (In thousands) Products transferred at a point in time $ 791,486 $ 413,062 $ 1,204,548 $ 2,206,252 $ 1,204,662 $ 3,410,914 Products and services transferred over time 190,329 45,804 236,133 500,421 131,434 631,855 Consolidated net sales $ 981,815 $ 458,866 $ 1,440,681 $ 2,706,673 $ 1,336,096 $ 4,042,769 |
Schedule of Product Warranty Liability | Changes in the accrued product warranty obligation were as follows: Nine Months Ended September 30, 2022 2021 (In thousands) Balance at the beginning of the period $ 27,478 $ 27,839 Accruals for warranties issued during the period 8,530 8,379 Settlements made during the period (8,769) (9,112) Warranty accruals related to acquired businesses and other during the period (1,080) 2,227 Balance at the end of the period $ 26,159 $ 29,333 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Number of Weighted Average Shares | The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (In thousands) Weighted average shares: Basic shares 229,500 231,171 230,360 230,811 Equity-based compensation plans 1,214 1,829 1,315 1,901 Diluted shares 230,714 233,000 231,675 232,712 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Assets Measured on Recurring Basis | The following table provides the Company’s assets that are measured at fair value on a recurring basis, consistent with the fair value hierarchy, at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 Fair Value Fair Value (In thousands) Mutual fund investments $ 8,866 $ 10,703 |
Fair Value Disclosures of Financial Instrument Liabilities | The following table provides the estimated fair values of the Company’s financial instrument liabilities, for which fair value is measured for disclosure purposes only, compared to the recorded amounts at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 Recorded Amount Fair Value Recorded Amount Fair Value (In thousands) Long-term debt (including current portion) $ (2,088,231) $ (1,910,792) $ (2,233,705) $ (2,378,930) |
Inventories, net (Tables)
Inventories, net (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Inventory Disclosure [Abstract] | |
Inventories | September 30, December 31, (In thousands) Finished goods and parts $ 128,409 $ 89,985 Work in process 151,456 122,356 Raw materials and purchased parts 745,265 556,834 Total inventories, net $ 1,025,130 $ 769,175 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Leases [Abstract] | |
Components of Lease Expense | The components of lease expense were as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) Operating lease cost $ 16,407 $ 13,560 $ 47,131 $ 37,083 Variable lease cost 2,479 1,737 7,131 4,609 Total lease cost $ 18,886 $ 15,297 $ 54,262 $ 41,692 |
Supplemental Balance Sheet Information Related to Leases | Supplemental balance sheet information related to leases was as follows: September 30, December 31, (In thousands) Right of use assets, net $ 161,217 $ 169,924 Lease liabilities included in Accrued Liabilities and other 45,434 47,353 Lease liabilities included in Other long-term liabilities 121,382 129,101 Total lease liabilities $ 166,816 $ 176,454 |
Maturities of Lease Liabilities | Maturities of lease liabilities as of September 30, 2022 were as follows: Lease Liability Maturity Analysis Operating Leases (In thousands) Remaining 2022 $ 13,154 2023 46,850 2024 35,684 2025 26,797 2026 20,476 Thereafter 36,390 Total lease payments 179,351 Less: imputed interest 12,535 $ 166,816 |
Acquisitions (Tables)
Acquisitions (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Business Combinations [Abstract] | |
Allocation of Aggregate Purchase Price of Acquired Net Assets | The following table represents the allocation of the purchase price for the net assets of the Navitar acquisition based on the estimated fair values at acquisition (in millions): Property, plant and equipment $ 8.9 Goodwill 71.1 Other intangible assets 95.0 Net working capital and other (1) 15.3 Total cash paid $ 190.3 ________________ (1) Includes $5.5 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal. |
Goodwill (Tables)
Goodwill (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Changes in Carrying Amounts of Goodwill by Segment | The changes in the carrying amounts of goodwill by segment were as follows: EIG EMG Total (In millions) Balance at December 31, 2021 $ 4,073.8 $ 1,164.9 $ 5,238.7 Goodwill acquired from 2022 acquisitions 71.1 — 71.1 Purchase price allocation adjustments and other 4.2 — 4.2 Foreign currency translation adjustments (70.1) (53.7) (123.8) Balance at September 30, 2022 $ 4,079.0 $ 1,111.2 $ 5,190.2 |
Income Taxes (Tables)
Income Taxes (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Reconciliation of Liability for Uncertain Tax Positions | The following is a reconciliation of the liability for uncertain tax positions (in millions): Balance at December 31, 2021 $ 147.0 Additions for tax positions 23.5 Reductions for tax positions (0.5) Balance at September 30, 2022 $ 170.0 |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Total Share-Based Compensation Expense | Total share-based compensation expense was as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) Stock option expense $ 3,043 $ 2,768 $ 9,866 $ 10,017 Restricted stock expense 4,800 4,848 14,831 16,765 Performance restricted stock unit expense 4,217 3,812 9,890 8,239 Total pre-tax expense $ 12,060 $ 11,428 $ 34,587 $ 35,021 |
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted | The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated: Nine Months Ended Year Ended December 31, 2021 Expected volatility 24.5 % 24.2 % Expected term (years) 5.0 5.0 Risk-free interest rate 2.33 % 0.85 % Expected dividend yield 0.65 % 0.66 % Black-Scholes-Merton fair value per stock option granted $ 32.54 $ 25.63 |
Summary of Stock Option Activity and Related Information | The following is a summary of the Company’s stock option activity and related information: Shares Weighted Weighted Aggregate (In thousands) (Years) (In millions) Outstanding at December 31, 2021 3,352 $ 76.08 Granted 608 134.69 Exercised (357) 64.44 Forfeited (101) 107.73 Outstanding at September 30, 2022 3,502 $ 86.52 6.2 $ 110.4 Exercisable at September 30, 2022 2,374 $ 72.84 5.0 $ 97.8 |
Summary of Nonvested Restricted Stock Activity and Related Information | The following is a summary of the Company’s non-vested restricted stock activity and related information: Shares Weighted (In thousands) Non-vested restricted stock outstanding at December 31, 2021 413 $ 96.07 Granted 182 134.55 Vested (156) 86.31 Forfeited (42) 108.42 Non-vested restricted stock outstanding at September 30, 2022 397 $ 116.26 The following is a summary of the Company’s non-vested performance restricted stock activity and related information: Shares Weighted (In thousands) Non-vested performance restricted stock outstanding at December 31, 2021 289 $ 85.29 Granted 87 134.69 Performance assumption change 1 66 81.76 Vested (161) 81.76 Forfeited (6) 98.07 Non-vested performance restricted stock outstanding at September 30, 2022 275 $ 101.98 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics. |
Retirement and Pension Plans (T
Retirement and Pension Plans (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Retirement Benefits [Abstract] | |
Components of Net Periodic Pension Benefit Expense (Income) | The components of net periodic pension benefit expense (income) were as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (In thousands) Defined benefit plans: Service cost $ 1,290 $ 2,009 $ 3,995 $ 6,060 Interest cost 4,949 4,563 15,101 13,711 Expected return on plan assets (14,812) (14,172) (45,113) (42,567) Amortization of net actuarial loss and other 2,074 7,550 6,371 16,282 Pension income (6,499) (50) (19,646) (6,514) Other plans: Defined contribution plans 9,217 7,792 32,289 24,208 Foreign plans and other 2,027 2,074 6,422 6,431 Total other plans 11,244 9,866 38,711 30,639 Total net pension expense $ 4,745 $ 9,816 $ 19,065 $ 24,125 |
Revenues - Outstanding Contract
Revenues - Outstanding Contract Asset and (Liability) Accounts (Detail) - USD ($) $ in Thousands | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | ||||
Contract assets | $ 111,687 | $ 82,986 | $ 95,274 | $ 68,971 |
Change in contract assets – increase (decrease) | 16,413 | 14,015 | ||
Contract liabilities | 371,411 | 311,674 | $ 328,816 | $ 215,093 |
Change in contract liabilities – (increase) decrease | (42,595) | (96,581) | ||
Net change | $ (26,182) | $ (82,566) |
Revenues - Additional Informati
Revenues - Additional Information (Detail) - USD ($) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Revenue recognized from contract liabilities | $ 252,400 | $ 179,100 | |
Customer advanced payments | 39,200 | $ 30,100 | |
Accounts and notes receivable, net | 876,460 | 829,213 | |
Allowance for notes and loans receivable | $ 12,000 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01 | |||
Performance obligation, expected timing of satisfaction, period | 3 months | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01 | |||
Revenue, remaining performance obligation | $ 520,600 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |||
Revenue, remaining performance obligation | $ 342,500 | ||
Performance obligation, expected timing of satisfaction, period | 1 year | ||
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01 | |||
Performance obligation, expected timing of satisfaction, period | 2 years | ||
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |||
Performance obligation, expected timing of satisfaction, period | 3 years |
Revenues - Information About Op
Revenues - Information About Operations in Different Geographic Areas (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Segment Reporting Information [Line Items] | ||||
Net sales | $ 1,551,786 | $ 1,440,681 | $ 4,524,863 | $ 4,042,769 |
United States | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 819,597 | 739,599 | 2,327,003 | 2,059,633 |
United Kingdom | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 47,103 | 58,204 | 154,359 | 159,419 |
European Union countries | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 214,362 | 219,104 | 666,694 | 639,526 |
Asia | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 334,807 | 307,687 | 979,523 | 849,745 |
Other foreign countries | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 135,917 | 116,087 | 397,284 | 334,446 |
International | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 732,189 | 701,082 | 2,197,860 | 1,983,136 |
Non-US | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 415,400 | 391,000 | 1,217,200 | 1,087,300 |
Electronic Instruments Group | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 1,054,124 | 981,815 | 3,070,131 | 2,706,673 |
Electronic Instruments Group | United States | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 554,048 | 509,075 | 1,589,641 | 1,393,015 |
Electronic Instruments Group | United Kingdom | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 18,409 | 25,358 | 65,414 | 67,954 |
Electronic Instruments Group | European Union countries | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 113,935 | 117,035 | 344,074 | 338,556 |
Electronic Instruments Group | Asia | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 264,432 | 242,063 | 776,084 | 657,478 |
Electronic Instruments Group | Other foreign countries | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 103,300 | 88,284 | 294,918 | 249,670 |
Electronic Instruments Group | International | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 500,076 | 472,740 | 1,480,490 | 1,313,658 |
Electromechanical Group | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 497,662 | 458,866 | 1,454,732 | 1,336,096 |
Electromechanical Group | United States | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 265,549 | 230,524 | 737,362 | 666,618 |
Electromechanical Group | United Kingdom | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 28,694 | 32,846 | 88,945 | 91,465 |
Electromechanical Group | European Union countries | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 100,427 | 102,069 | 322,620 | 300,970 |
Electromechanical Group | Asia | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 70,375 | 65,624 | 203,439 | 192,267 |
Electromechanical Group | Other foreign countries | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 32,617 | 27,803 | 102,366 | 84,776 |
Electromechanical Group | International | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | $ 232,113 | $ 228,342 | $ 717,370 | $ 669,478 |
Revenues - Major Products and S
Revenues - Major Products and Services in Reportable Segments (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 1,551,786 | $ 1,440,681 | $ 4,524,863 | $ 4,042,769 |
Process and analytical instrumentation | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 758,868 | 661,243 | 2,219,821 | 1,881,923 |
Aerospace and power | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 438,945 | 451,243 | 1,258,081 | 1,204,060 |
Automation and engineered solutions | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 353,973 | 328,195 | 1,046,961 | 956,786 |
Electronic Instruments Group | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 1,054,124 | 981,815 | 3,070,131 | 2,706,673 |
Electronic Instruments Group | Process and analytical instrumentation | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 758,868 | 661,243 | 2,219,821 | 1,881,923 |
Electronic Instruments Group | Aerospace and power | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 295,256 | 320,572 | 850,310 | 824,750 |
Electronic Instruments Group | Automation and engineered solutions | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 0 | 0 | 0 | 0 |
Electromechanical Group | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 497,662 | 458,866 | 1,454,732 | 1,336,096 |
Electromechanical Group | Process and analytical instrumentation | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 0 | 0 | 0 | 0 |
Electromechanical Group | Aerospace and power | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 143,689 | 130,671 | 407,771 | 379,310 |
Electromechanical Group | Automation and engineered solutions | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 353,973 | $ 328,195 | $ 1,046,961 | $ 956,786 |
Revenues - Timing of Revenue Re
Revenues - Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 1,551,786 | $ 1,440,681 | $ 4,524,863 | $ 4,042,769 |
Products transferred at a point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 1,305,677 | 1,204,548 | 3,794,733 | 3,410,914 |
Products and services transferred over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 246,109 | 236,133 | 730,130 | 631,855 |
Electronic Instruments Group | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 1,054,124 | 981,815 | 3,070,131 | 2,706,673 |
Electronic Instruments Group | Products transferred at a point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 869,455 | 791,486 | 2,522,351 | 2,206,252 |
Electronic Instruments Group | Products and services transferred over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 184,669 | 190,329 | 547,780 | 500,421 |
Electromechanical Group | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 497,662 | 458,866 | 1,454,732 | 1,336,096 |
Electromechanical Group | Products transferred at a point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 436,222 | 413,062 | 1,272,382 | 1,204,662 |
Electromechanical Group | Products and services transferred over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 61,440 | $ 45,804 | $ 182,350 | $ 131,434 |
Revenues - Changes in Accrued P
Revenues - Changes in Accrued Product Warranty Obligation (Detail) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Movement in Standard Product Warranty Accrual [Roll Forward] | ||
Balance at the beginning of the period | $ 27,478 | $ 27,839 |
Accruals for warranties issued during the period | 8,530 | 8,379 |
Settlements made during the period | (8,769) | (9,112) |
Warranty accruals related to acquired businesses and other during the period | (1,080) | 2,227 |
Balance at the end of the period | $ 26,159 | $ 29,333 |
Earnings Per Share - Number of
Earnings Per Share - Number of Weighted Average Shares (Detail) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Weighted average common shares outstanding: | ||||
Basic shares | 229,500 | 231,171 | 230,360 | 230,811 |
Equity-based compensation plans | 1,214 | 1,829 | 1,315 | 1,901 |
Diluted shares | 230,714 | 233,000 | 231,675 | 232,712 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value of Assets Measured on Recurring Basis (Detail) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Mutual fund investments | $ 8,866 | $ 10,703 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Detail) € in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 EUR (€) | Sep. 30, 2022 CAD ($) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net | $ 0 | $ 0 | $ 0 | $ 0 | ||
Euro Forward Contract | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Foreign currency contract, asset, fair value disclosure | € | € 40 | |||||
Canadian Dollar Forward Contract | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
Foreign currency contract, asset, fair value disclosure | $ 22 |
Fair Value Measurements - Fai_2
Fair Value Measurements - Fair Value Disclosures of Financial Instrument Liabilities (Detail) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Recorded Amount | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Long-term debt, net (including current portion) | $ (2,088,231) | $ (2,233,705) |
Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Long-term debt, net (including current portion) | $ (1,910,792) | $ (2,378,930) |
Hedging Activities - Additional
Hedging Activities - Additional Information (Detail) - Foreign Exchange Contract - Designated as Hedging Instrument $ in Millions | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Derivative [Line Items] | |
Percentage of effectiveness on net investment hedges | 100% |
Currency remeasurement gain | $ 139.3 |
British-Pound-Denominated Loans | |
Derivative [Line Items] | |
Hedge against net investment in foreign subsidiaries | 250.4 |
Euro Loan | |
Derivative [Line Items] | |
Hedge against net investment in foreign subsidiaries | $ 523.7 |
Inventories, net - Inventories
Inventories, net - Inventories (Detail) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Inventory Disclosure [Abstract] | ||
Finished goods and parts | $ 128,409 | $ 89,985 |
Work in process | 151,456 | 122,356 |
Raw materials and purchased parts | 745,265 | 556,834 |
Total inventories, net | $ 1,025,130 | $ 769,175 |
Leases - Additional Information
Leases - Additional Information (Details) | Sep. 30, 2022 |
Lessee, Lease, Description [Line Items] | |
Operating lease, weighted average remaining lease term | 5 years |
Leases- Components of Lease Exp
Leases- Components of Lease Expense (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Leases [Abstract] | ||||
Operating lease cost | $ 16,407 | $ 13,560 | $ 47,131 | $ 37,083 |
Variable lease cost | 2,479 | 1,737 | 7,131 | 4,609 |
Total lease cost | $ 18,886 | $ 15,297 | $ 54,262 | $ 41,692 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information Related to Leases (Detail) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Leases [Abstract] | ||
Right of use assets, net | $ 161,217 | $ 169,924 |
Operating lease, liability, current, statement of financial position | Accrued liabilities and other | Accrued liabilities and other |
Lease liabilities included in Accrued Liabilities and other | $ 45,434 | $ 47,353 |
Operating lease, liability, noncurrent, statement of financial position | Other long-term liabilities | Other long-term liabilities |
Lease liabilities included in Other long-term liabilities | $ 121,382 | $ 129,101 |
Total lease liabilities | $ 166,816 | $ 176,454 |
Leases - Maturities of lease li
Leases - Maturities of lease liabilities (Detail) - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
Lessee, Operating Lease, Liability, Payment, Due [Abstract] | ||
Remaining 2022 | $ 13,154 | |
2023 | 46,850 | |
2024 | 35,684 | |
2025 | 26,797 | |
2026 | 20,476 | |
Thereafter | 36,390 | |
Total lease payments | 179,351 | |
Less: imputed interest | 12,535 | |
Total lease liabilities | $ 166,816 | $ 176,454 |
Acquisitions - Additional Infor
Acquisitions - Additional Information (Detail) $ in Thousands, $ in Millions | 1 Months Ended | 2 Months Ended | 9 Months Ended | ||
Oct. 31, 2022 USD ($) | Oct. 31, 2022 CAD ($) | Apr. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | |
Business Acquisition [Line Items] | |||||
Purchases of businesses, net of cash acquired | $ 190,321 | $ 1,839,664 | |||
2021 Consolidated Acquisition | |||||
Business Acquisition [Line Items] | |||||
Purchases of businesses, net of cash acquired | $ (190,300) | ||||
Business acquisition, goodwill, expected tax deductible amount | 52,000 | ||||
Two Thousand And Twenty Consolidated Acquisition [Member] | |||||
Business Acquisition [Line Items] | |||||
Other intangible assets | 95,000 | ||||
Finite-lived intangible assets acquired | 79,800 | ||||
Expected amortization, remainder of fiscal year | 5,000 | ||||
Future amortization expense, year two | 5,000 | ||||
Future amortization expense, year five | 5,000 | ||||
Future amortization expense, year four | 5,000 | ||||
Future amortization expense, year three | 5,000 | ||||
Future amortization expense, year one | 5,000 | ||||
Two Thousand And Twenty Consolidated Acquisition [Member] | Trade Names | |||||
Business Acquisition [Line Items] | |||||
Indefinite-lived intangible trade names acquired | 15,200 | ||||
Two Thousand And Twenty Consolidated Acquisition [Member] | Customer Relationship | |||||
Business Acquisition [Line Items] | |||||
Finite-lived intangible assets acquired | $ 64,600 | ||||
Two Thousand And Twenty Consolidated Acquisition [Member] | Customer Relationship | Minimum | |||||
Business Acquisition [Line Items] | |||||
Amortization period for finite-lived intangible asset | 17 years | ||||
Two Thousand And Twenty Consolidated Acquisition [Member] | Purchased Technology | |||||
Business Acquisition [Line Items] | |||||
Finite-lived intangible assets acquired | $ 15,200 | ||||
Two Thousand And Twenty Consolidated Acquisition [Member] | Purchased Technology | Minimum | |||||
Business Acquisition [Line Items] | |||||
Amortization period for finite-lived intangible asset | 17 years | ||||
RTDS Technologies | Subsequent Event | |||||
Business Acquisition [Line Items] | |||||
Payments to acquire businesses, gross | $ 240,000 | $ 325 |
Acquisitions - Allocation of Ag
Acquisitions - Allocation of Aggregate Purchase Price of Acquired Net Assets (Detail) - USD ($) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | |||
Goodwill | $ 5,190,196 | $ 5,238,726 | |
Total cash paid | 190,321 | $ 1,839,664 | |
Two Thousand Twenty One Consolidated Acquisitions | |||
Business Acquisition [Line Items] | |||
Property, plant and equipment | 8,900 | ||
Goodwill | 71,100 | ||
Other intangible assets | 95,000 | ||
Net working capital and other | 15,300 | ||
Total cash paid | 190,300 | ||
Accounts receivable included in purchase price | $ 5,500 |
Goodwill - Changes in Carrying
Goodwill - Changes in Carrying Amounts of Goodwill by Segment (Detail) $ in Thousands | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Goodwill [Roll Forward] | |
Goodwill, beginning balance | $ 5,238,726 |
Goodwill acquired from 2022 acquisitions | 71,100 |
Purchase price allocation adjustments and other | 4,200 |
Foreign currency translation adjustments | (123,800) |
Goodwill, ending balance | 5,190,196 |
Electronic Instruments Group | |
Goodwill [Roll Forward] | |
Goodwill, beginning balance | 4,073,800 |
Goodwill acquired from 2022 acquisitions | 71,100 |
Purchase price allocation adjustments and other | 4,200 |
Foreign currency translation adjustments | (70,100) |
Goodwill, ending balance | 4,079,000 |
Electromechanical Group | |
Goodwill [Roll Forward] | |
Goodwill, beginning balance | 1,164,900 |
Goodwill acquired from 2022 acquisitions | 0 |
Purchase price allocation adjustments and other | 0 |
Foreign currency translation adjustments | (53,700) |
Goodwill, ending balance | $ 1,111,200 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Gross unrecognized tax benefits | $ 170 | $ 147 | |
The total amount of unrecognized tax benefits that would impact tax rate, if recognized | $ 125.3 | ||
Effective tax rate | 19% | 19.50% |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Liability for Uncertain Tax Positions (Detail) $ in Millions | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |
Balance at the beginning of the year | $ 147 |
Additions for tax positions | 23.5 |
Reductions for tax positions | (0.5) |
Balance at the end of the year | $ 170 |
Debt (Details)
Debt (Details) - USD ($) | May 12, 2022 | Sep. 30, 2022 | May 11, 2022 |
Secured Debt | |||
Debt Instrument [Line Items] | |||
Extinguishment of debt, amount | $ 800,000,000 | ||
Long-term debt, gross | $ 274,000,000 | ||
Line of Credit | Revolving Credit Facility | JPMorgan Chase Bank, N.A. | |||
Debt Instrument [Line Items] | |||
Line of credit facility, maximum borrowing capacity | $ 2,300,000,000 | $ 1,500,000,000 |
Share-Based Compensation - Tota
Share-Based Compensation - Total Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share-Based Payment Arrangement [Abstract] | ||||
Stock option expense | $ 3,043 | $ 2,768 | $ 9,866 | $ 10,017 |
Restricted stock expense | 4,800 | 4,848 | 14,831 | 16,765 |
Performance restricted stock unit expense | 4,217 | 3,812 | 9,890 | 8,239 |
Total pre-tax expense | $ 12,060 | $ 11,428 | $ 34,587 | $ 35,021 |
Share-Based Compensation - Weig
Share-Based Compensation - Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted (Detail) - $ / shares | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 | Dec. 31, 2021 | |
Share-Based Payment Arrangement [Abstract] | ||
Expected volatility | 24.50% | 24.20% |
Expected term (years) | 5 years | 5 years |
Risk-free interest rate | 2.33% | 0.85% |
Expected dividend yield | 0.65% | 0.66% |
Black-Scholes-Merton fair value per stock option granted (in usd per share) | $ 32.54 | $ 25.63 |
Share-Based Compensation - Summ
Share-Based Compensation - Summary of Stock Option Activity and Related Information (Detail) $ / shares in Units, shares in Thousands, $ in Millions | 9 Months Ended |
Sep. 30, 2022 USD ($) $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | |
Beginning balance, outstanding (in shares) | shares | 3,352 |
Granted (in shares) | shares | 608 |
Exercised (in shares) | shares | (357) |
Forfeited (in shares) | shares | (101) |
Ending balance, outstanding (in shares) | shares | 3,502 |
Ending balance, exercisable (in shares) | shares | 2,374 |
Weighted Average Exercise Price | |
Beginning balance, outstanding, weighted average exercise price (in usd per share) | $ / shares | $ 76.08 |
Granted, weighted average exercise price (in usd per share) | $ / shares | 134.69 |
Exercised, weighted average exercise price (in usd per share) | $ / shares | 64.44 |
Forfeited, weighted average exercise price (in usd per share) | $ / shares | 107.73 |
Ending balance, outstanding, weighted average exercise price (in shares) | $ / shares | 86.52 |
Ending balance, exercisable, weighted average exercise price (in usd per share) | $ / shares | $ 72.84 |
Weighted Average Remaining Contractual Life | |
Ending balance, outstanding, weighted average remaining contractual life | 6 years 2 months 12 days |
Ending balance, exercisable, weighted average remaining contractual life | 5 years |
Aggregate Intrinsic Value | |
Ending balance, outstanding, aggregate intrinsic value | $ | $ 110.4 |
Ending balance, exercisable, aggregate intrinsic value | $ | $ 97.8 |
Share-Based Compensation - Addi
Share-Based Compensation - Additional Information (Detail) - USD ($) shares in Thousands, $ in Millions | 1 Months Ended | 9 Months Ended | |
Mar. 31, 2022 | Sep. 30, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Aggregate intrinsic value of stock options exercised | $ 23 | ||
Total fair value of stock options vested | 11.3 | ||
Expected future pre-tax compensation expense, nonvested stock options | $ 20.9 | ||
Weighted average period to recognize expected future pre-tax compensation expense | 2 years | ||
Nonvested restricted stock outstanding (in shares) | 400 | ||
Share-based payment arrangement, nonvested award, cost not yet recognized, amount | $ 8.8 | ||
Share-based payment award, options, outstanding (in shares) | 3,502 | 3,352 | |
Non vested Stock options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Nonvested stock options outstanding (in shares) | 1,100 | ||
Restricted Shares | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average period to recognize expected future pre-tax compensation expense | 2 years | ||
Total fair value of vested restricted stock | $ 13.5 | ||
Expected future pre-tax compensation expense, nonvested restricted shares | $ 32.3 | ||
Nonvested restricted stock outstanding (in shares) | 397 | 413 | |
Performance Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average period to recognize expected future pre-tax compensation expense | 1 year | ||
Nonvested restricted stock outstanding (in shares) | 275 | 289 | |
Share-based payment award, options, outstanding (in shares) | 300 | ||
Officers And Key Management Employees | Performance Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Cliff vesting period | 3 years | ||
Minimum | Officers And Key Management Employees | Performance Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting rate | 0% | ||
Maximum | Officers And Key Management Employees | Performance Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation, vesting rate | 200% |
Share-Based Compensation - Su_2
Share-Based Compensation - Summary of Nonvested Restricted Stock Activity and Related Information (Detail) shares in Thousands | 9 Months Ended |
Sep. 30, 2022 $ / shares shares | |
Shares | |
Non-vested restricted stock outstanding at end of period (in shares) | 400 |
Restricted Shares | |
Shares | |
Non-vested restricted stock outstanding at beginning of period (in shares) | 413 |
Granted (in shares) | 182 |
Vested (in shares) | (156) |
Forfeited (in shares) | (42) |
Non-vested restricted stock outstanding at end of period (in shares) | 397 |
Weighted Average Grant Date Fair Value | |
Non-vested restricted stock outstanding at beginning of period (in usd per share) | $ / shares | $ 96.07 |
Granted (in usd per share) | $ / shares | 134.55 |
Vested (in usd per share) | $ / shares | 86.31 |
Forfeited (in usd per share) | $ / shares | 108.42 |
Non-vested restricted stock outstanding at end of period (in usd per share) | $ / shares | $ 116.26 |
Performance Restricted Stock Units | |
Shares | |
Non-vested restricted stock outstanding at beginning of period (in shares) | 289 |
Granted (in shares) | 87 |
Performance assumption change (in shares) | 66 |
Vested (in shares) | (161) |
Forfeited (in shares) | (6) |
Non-vested restricted stock outstanding at end of period (in shares) | 275 |
Weighted Average Grant Date Fair Value | |
Non-vested restricted stock outstanding at beginning of period (in usd per share) | $ / shares | $ 85.29 |
Granted (in usd per share) | $ / shares | 134.69 |
Performance assumption change (in usd per share) | $ / shares | 81.76 |
Vested (in usd per share) | $ / shares | 81.76 |
Forfeited (in usd per share) | $ / shares | 98.07 |
Non-vested restricted stock outstanding at end of period (in usd per share) | $ / shares | $ 101.98 |
Retirement and Pension Plans -
Retirement and Pension Plans - Components of Net Periodic Pension Benefit Expense (Income) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Defined benefit plans: | ||||
Service cost | $ 1,290 | $ 2,009 | $ 3,995 | $ 6,060 |
Interest cost | 4,949 | 4,563 | 15,101 | 13,711 |
Expected return on plan assets | (14,812) | (14,172) | (45,113) | (42,567) |
Amortization of net actuarial loss and other | 2,074 | 7,550 | 6,371 | 16,282 |
Pension income | (6,499) | (50) | (19,646) | (6,514) |
Other plans: | ||||
Defined contribution plans | 9,217 | 7,792 | 32,289 | 24,208 |
Foreign plans and other | 2,027 | 2,074 | 6,422 | 6,431 |
Total other plans | 11,244 | 9,866 | 38,711 | 30,639 |
Total net pension expense | $ 4,745 | $ 9,816 | $ 19,065 | $ 24,125 |
Retirement and Pension Plans _2
Retirement and Pension Plans - Additional Information (Detail) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Retirement Benefits [Abstract] | ||
Defined benefit pension plan contributions | $ 5.2 | $ 6.4 |
Contingencies - Additional Info
Contingencies - Additional Information (Detail) $ in Millions | 9 Months Ended | |
Sep. 30, 2022 USD ($) site | Dec. 31, 2021 USD ($) | |
Site Contingency [Line Items] | ||
Number of non-owned sites company is named potentially responsible party | 13 | |
Number of non-owned sites the Company is identified as a de minimis party | 12 | |
Number of non-owned sites company is in agreement on amount of de minimis settlement | 8 | |
Number of non-owned sites company is continuing to investigate | 4 | |
Total environmental reserves | $ | $ 39.6 | $ 37.2 |
Payments for environmental liabilities | $ | (6.4) | |
HCC Industries | ||
Site Contingency [Line Items] | ||
Environmental expense | $ | $ 8.8 |